title: Leptin responsiveness of mice deficient in corticotrophin-releasing hormone receptor type 2.
abstract: Leptin acts centrally to inhibit food intake and increase energy expenditure. Corticotrophin-releasing hormone (CRH) is one of the neuropeptides that may contribute to leptin-induced hypophagia and thermogenesis. Acute leptin administration increases CRH mRNA expression in the paraventricular nucleus of the hypothalamus and CRH receptor type 2 (CRHR2) expression in the ventromedial nucleus of the hypothalamus. Studies described here used male and female CRHR2 knockout (KO) mice and wild-type (WT) controls to test the importance of CRHR2 in mediating the effects of leptin on food intake, weight gain and body composition. Peripheral injections of 0.5 mg/kg leptin for 3 days inhibited food intake in female WT and male KO mice, but inhibited weight gain in female KO and male WT mice suggesting an important role for thermogenesis in mediating weight loss. A single third ventricle injection of 1 μg leptin inhibited 12 h food intake of all mice, 36 h cumulative intake of KO mice and weight loss in WT and KO female and WT male mice. A 12-day peripheral infusion of 10 μg leptin/day had no effect on food intake of any group, but significantly reduced carcass fat and protein content of all mice. These results indicate that CRHR2 are not essential for the effects of leptin on food intake, body weight or body composition. Leptin response seems to be determined by a combination of mouse gender and genotype, but CRHR2 KO mice may have an extended response to central leptin injections compared with their WT controls.
authors.affiliation: Department of Foods and Nutrition, University of Georgia, Athens, GA 30912, USA.
authors.forename: Ruth B S
authors.initials: RB
authors.lastname: Harris
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D005260:Female; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D020738:Leptin / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D018019:Receptors, Corticotropin-Releasing Hormone / Q000235:genetics* / Q000378:metabolism
chemical_list: D020738:Leptin; D018019:Receptors, Corticotropin-Releasing Hormone
references.citation: Brain Res. 2003 Feb 21;964(1):107-15
references.pmid: 12573518
references.citation: Endocrinology. 1998 Apr;139(4):1524-32
references.pmid: 9528930
references.citation: Physiol Behav. 2003 Apr;78(4-5):543-55
references.pmid: 12782207
references.citation: Eur J Pharmacol. 1996 May 15;303(3):213-6
references.pmid: 8813571
references.citation: Cell Metab. 2010 Jan;11(1):77-83
references.pmid: 20074530
references.citation: Nat Genet. 2000 Apr;24(4):410-4
references.pmid: 10742108
references.citation: Recent Prog Horm Res. 2004;59:287-304
references.pmid: 14749507
references.citation: J Am Diet Assoc. 1997 Jan;97(1):54-8; quiz 59-60
references.pmid: 8990418
references.citation: Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7570-5
references.pmid: 11416224
references.citation: J Nutr. 1991 Jul;121(7):1075-80
references.pmid: 2051227
references.citation: Brain Res. 1988 Mar 8;443(1-2):63-9
references.pmid: 2834018
references.citation: J Endocrinol. 2006 Oct;191(1):179-88
references.pmid: 17065401
references.citation: Nature. 2001 May 24;411(6836):480-4
references.pmid: 11373681
references.citation: Am J Physiol. 1988 Sep;255(3 Pt 1):E255-9
references.pmid: 3262311
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Jan;284(1):R87-100
references.pmid: 12482747
references.citation: Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E337-45
references.pmid: 19952342
references.citation: Neuroendocrinology. 1998 Jan;67(1):29-36
references.pmid: 9485166
references.citation: J Comp Neurol. 1998 Jun 15;395(4):535-47
references.pmid: 9619505
references.citation: J Pharmacol Exp Ther. 2003 Apr;305(1):385-93
references.pmid: 12649393
references.citation: Nat Neurosci. 1998 Jun;1(2):103
references.pmid: 10195123
references.citation: Diabetes. 1997 Dec;46(12):2119-23
references.pmid: 9392508
references.citation: J Clin Invest. 1996 Sep 1;98(5):1101-6
references.pmid: 8787671
references.citation: Endocrinology. 2003 Aug;144(8):3547-54
references.pmid: 12865337
references.citation: J Neurosci. 1995 Oct;15(10):6340-50
references.pmid: 7472399
references.citation: Annu Rev Pharmacol Toxicol. 2004;44:525-57
references.pmid: 14744257
references.citation: J Neurosci. 2005 Feb 9;25(6):1514-22
references.pmid: 15703405
references.citation: Nat Med. 1997 May;3(5):575-9
references.pmid: 9142131
references.citation: J Comp Neurol. 2000 Dec 11;428(2):191-212
references.pmid: 11064361
references.citation: Stress. 2010 May;13(3):203-13
references.pmid: 20392192
references.citation: Nature. 1994 Dec 1;372(6505):425-32
references.pmid: 7984236
references.citation: Neuroendocrinology. 1999 Jun;69(6):417-23
references.pmid: 10364693
references.citation: Psychopharmacology (Berl). 2004 Oct;176(1):30-8
references.pmid: 15071721
references.citation: J Neurosci. 2003 Jun 15;23(12):5295-301
references.pmid: 12832554
references.citation: Neuroreport. 1997 Mar 24;8(5):1131-4
references.pmid: 9175099
references.citation: Diabetes. 1998 Jun;47(6):890-3
references.pmid: 9604864
references.citation: J Neuroendocrinol. 1999 Apr;11(4):307-14
references.pmid: 10223285
references.citation: Am J Physiol. 1998 Oct;275(4):R1138-45
references.pmid: 9756544